Andersen JW - Search Results

1

Long-term survival in acute myeloid leukemia: the Eastern Cooperative Oncology Group experience.

Bennett JM, Young ML, Andersen JW, Cassileth PA, Tallman MS, Paietta E, Wiernik PH, Rowe JM. Bennett JM, et al. Among authors: andersen jw. Cancer. 1997 Dec 1;80(11 Suppl):2205-9. Cancer. 1997. PMID: 9395035

2

Post-remission therapy in adults with acute myelogenous leukemia: the Eastern Cooperative Oncology Group (ECOG) experience.

Rowe JM, Andersen JW, Cassileth PA, Oken MM, Bennett JM, Wiernik PH. Rowe JM, et al. Among authors: andersen jw. Leukemia. 1992 Nov;6 Suppl 4:75-7. Leukemia. 1992. PMID: 1434840 Clinical Trial. No abstract available.

3

Escalating the intensity of post-remission therapy improves the outcome in acute myeloid leukemia: the ECOG experience. The Eastern Cooperative Oncology Group.

Cassileth PA, Andersen JW, Bennett JM, Harrington DP, Hines JD, Lazarus HM, Mazza JJ, McGlave PP, O'Connell MJ, Paietta E, et al. Cassileth PA, et al. Among authors: andersen jw. Leukemia. 1992;6 Suppl 2:116-9. Leukemia. 1992. PMID: 1578910 Clinical Trial.

4

Long term survival in acute myeloid leukemia: the Eastern Cooperative Oncology Group (ECOG) experience.

Bennett JM, Andersen JW, Cassileth PA. Bennett JM, et al. Among authors: andersen jw. Leuk Res. 1991;15(4):223-7. doi: 10.1016/0145-2126(91)90124-c. Leuk Res. 1991. PMID: 2030603

5

A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490).

Rowe JM, Andersen JW, Mazza JJ, Bennett JM, Paietta E, Hayes FA, Oette D, Cassileth PA, Stadtmauer EA, Wiernik PH. Rowe JM, et al. Among authors: andersen jw. Blood. 1995 Jul 15;86(2):457-62. Blood. 1995. PMID: 7605984 Free article. Clinical Trial.

6

Age and Hodgkin's disease: the impact of competing risks and possibly salvage therapy on long term survival: an E.C.O.G. study.

Bennett JM, Andersen JW, Begg CB, Glick JH. Bennett JM, et al. Among authors: andersen jw. Leuk Res. 1993 Oct;17(10):825-32. doi: 10.1016/0145-2126(93)90147-d. Leuk Res. 1993. PMID: 8412294 Clinical Trial.

7

Mitoxantrone and etoposide in patients with relapsed and refractory acute nonlymphocytic leukemia.

Rowe JM, Mazza JJ, Hines JD, Cassileth PA, Oken MM, Bennett JM, Andersen J. Rowe JM, et al. Haematol Blood Transfus. 1990;33:326-9. doi: 10.1007/978-3-642-74643-7_61. Haematol Blood Transfus. 1990. PMID: 2182427 Clinical Trial. No abstract available.

8

A new approach to analyzing the utility of immunophenotyping for predicting clinical outcome in acute leukemia. Eastern Cooperative Oncology Group.

Paietta E, Andersen J, Wiernik PH. Paietta E, et al. Leukemia. 1996 Jan;10(1):1-4. Leukemia. 1996. PMID: 8558912 Review. No abstract available.

9

Acute myeloid leukaemia expressing the leucocyte integrin CD11b-a new leukaemic syndrome with poor prognosis: result of an ECOG database analysis. Eastern Cooperative Oncology Group.

Paietta E, Andersen J, Yunis J, Rowe JM, Cassileth PA, Tallman MS, Bennett JM, Wiernik PH. Paietta E, et al. Br J Haematol. 1998 Feb;100(2):265-72. doi: 10.1046/j.1365-2141.1998.00561.x. Br J Haematol. 1998. PMID: 9488612 Free article.

10

13-cis-retinoic acid in the treatment of elderly patients with acute myeloid leukemia. A phase II pilot study of the Eastern Cooperative Oncology Group.

Kramer ZB, Boros L, Wiernik PH, Andersen J, Bennett JM, Cassileth P, Oken M. Kramer ZB, et al. Cancer. 1991 Mar 15;67(6):1484-6. doi: 10.1002/1097-0142(19910315)67:6<1484::aid-cncr2820670603>3.0.co;2-3. Cancer. 1991. PMID: 2001535 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters